KIMBERLY ROGERS: Open Payments
NPI 1306885819 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 24 payments from 10 companies in 2025. Trend: 2023 $497 · 2024 $494 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $99 |
| PFIZER INC. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Dexcom, Inc. | 2 | $60 |
| Abbott Laboratories | 2 | $48 |
| Novo Nordisk Inc | 3 | $46 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: UBRELVY, AIRSUPRA, Dexcom G6 Transmitter, PREVNAR 20, FREESTYLE LIBRE 3, Wegovy, BREZTRI, LINZESS.
Industry payments across NC — which companies pay providers there.
